• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Hester Biosciences Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 4164.0
  • ISIN : INE782E01017
1,254.50 -80 (-5.98%)
  • As on 31 Mar 2025 (EOD)

  • Today’s Low

    1,242.95

  • Today’s High

    1,355.95

  • Open

    1,335.00

  • Perv Close

    1,334.35

  • 52W Low

    1,242.95

  • 52W High

    3,379.00

Key Indicators

  • P/E(TTM)

    35.99

  • Mar.Cap (₹Cr.)

    1,067.19

  • Div & Yield %

    0.48

  • Book Value(₹)

    382.47

  • Debt-Equity Ratio

    -5.98

  • AGM Date

    28-Mar-2025

  • EPS

    34.84

  • P/E Ratio

    35.99

Financials Ratios

  • Debt-Equity Ratio

    0.91

  • Mar.Cap (₹Cr.)

    1,067.19

  • RONW (%)

    7.41

  • ROCE (%)

    8.74

Score Board

  • Equity (₹ in Cr.)

    8.51

  • BV (₹)

    382.50

  • Sales( ₹ in Cr.)

    285.16

  • NP (in Cr.)

    27.14

  • NP Var(%)

    -16.0

  • Div%

    60.0

  • CPS (₹)

    43.40

  • EPS (₹)

    31.90

  • Traded Value (₹ in Lakhs)

    1,066.68

  • 52 Week High

    3,379.00

  • 52 Week Low

    1,242.95

  • Price BSE

    1254.0

  • Price NSE

    1,255.00

  • Market Capital( in Cr.)

    1,066.68

  • P/C Ratio

    28.90

  • P/E Ratio

    39.30

  • Price Vs.BV

    31.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 285.16 254.00 219.35 208.48 169.43 171.19
Excise Duty 283.46 249.09 215.50 190.90 154.02 157.73
Net Sales 285.16 254.00 219.35 208.48 169.43 171.19
Other Income 4.26 5.32 4.66 1.65 2.93 3.10
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 289.42 259.32 224.01 210.13 172.35 174.28
EXPENDITURE :
Raw Materials 283.46 249.09 215.50 190.90 154.02 157.73
Power & Fuel Cost 283.46 249.09 215.50 190.90 154.02 157.73
Employee Cost 56.72 47.92 39.12 33.45 37.16 26.74
Other Manufacturing Expenses 4.37 4.55 5.26 5.00 3.95 1.65
Selling & Administrative Expenses 52.74 49.26 34.94 32.24 32.88 23.41
Miscellaneous Expenses 4.37 4.55 5.26 5.00 3.95 1.65
Less : Pre-operative Expenses Capitalised :
Total Expenditure 252.69 215.40 170.75 150.06 131.12 114.53
Operating Profit 24.34 17.51 15.63 12.39 13.48 22.41
Interest 5.09 6.50 2.47 3.95 5.03 3.54
Gross Profit 36.73 43.92 53.26 54.78 41.23 59.75
Depreciation 9.78 9.79 9.50 9.63 9.39 7.57
Profit Before Tax 36.73 43.92 53.26 54.78 41.23 59.75
Tax 9.64 10.73 14.25 16.37 11.81 15.24
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.06 0.86 -0.51 -1.48 -1.80 0.66
Reported Net Profit 27.16 32.34 39.52 39.90 31.22 43.85
Extraordinary Items 36.73 43.92 53.26 54.78 41.23 59.75
Adjusted Net Profit 27.16 32.34 39.52 39.90 31.22 43.85
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 5.10 6.81 8.51 8.51 5.61 9.36
P & L Balance carried down 27.16 32.34 39.52 39.90 31.22 43.85
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 60.00 80.00 100.00 100.00 66.00 110.00
Dividend Per Share(Rs) 6.00 8.00 10.00 10.00 6.60 11.00
Earnings Per Share-Unit Curr 31.93 38.02 46.45 46.90 36.70 51.55
Book Value 5.10 6.81 8.51 8.51 5.61 9.36
Book Value(Adj)-Unit Curr 5.10 6.81 8.51 8.51 5.61 9.36

Shareholding Pattern

  • Promoter Group

    53.73%

  • Public Share Holding

    46.27%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 803,955 803,955.00 803,955 803,955
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 803,955 9.45 803,955 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 336,838 3.96 336,838 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,430,151 40.32 3,430,151 8
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,766,989 44.28 3,766,989 11
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 50,519 0.59 50,519 17
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 144 0.00 144 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,500 0.02 1,500 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 52,163 0.61 52,163 20
2] Non Institution
Bodies Corporate 269,455 3.17 269,454 117
Clearing Members 79 0.00 79 4
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 501,093 5.89 501,093 363
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 233,366 2.74 233,266 337
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,248,243 14.67 1,248,243 17
Individuals holding nominal share capital up to Rs. 1 lakh 1,531,776 18.01 1,455,764 10,585
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 2,649 0.03 2,649 3
Others 85,402 1.00 85,402 1
Sub Total 3,883,758 45.65 3,807,645 11,440
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 8,506,865 100.00 8,430,752 11,473

Company Background

Hester Biosciences LtdPharmaceuticals - Indian - Formulations

  • Hester Biosciences Ltd
  • BSE Code : 4164.0
  • ISIN : INE782E01017

  • Incorporation Year

    1987

  • Registered Office

    1st Flr PushpakPachvati Circle
    Motilal Hirabhai Road, Ahmedabad,
    Gujarat-380006

  • Telephone

    91-079-26445107

  • FAX

    91-079-26445105

  • Chairman

    Bhupendra V Gandhi

  • Managing Director

    Rajiv D Gandhi

  • Company Secretary

  • Auditor

    Chandulal M Shah & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Link Intime India Pvt Ltd
    5th Floor 506 to 508,
    ABC-I Off C G Road ,Navrangpura
    Mumbai - Ahmedabad-380009

Hester Biosciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Hester Bios 1,253.90 289.42 285.16 35.99 8.51
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92